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Background: Exercise is an effective treatment for various chronic pain disorders, including 
fibromyalgia, chronic neck pain, osteoarthritis, rheumatoid arthritis, and chronic low back pain. 
Although the clinical benefits of exercise therapy in these populations are well established (i.e. 
evidence based), it is currently unclear whether exercise has positive effects on the processes 
involved in chronic pain (e.g. central pain modulation). 
Objectives: Reviewing the available evidence addressing the effects of exercise on central pain 
modulation in patients with chronic pain. 
Methods: Narrative review.
Results: Exercise activates endogenous analgesia in healthy individuals. The increased pain 
threshold following exercise is due to the release of endogenous opioids and activation of 
(supra)spinal nociceptive inhibitory mechanisms orchestrated by the brain. Exercise triggers the 
release of β-endorphins from the pituitary (peripherally) and the hypothalamus (centrally), which 
in turn enables analgesic effects by activating µ-opioid receptors peripherally and centrally, 
respectively. The hypothalamus, through its projections on the periaqueductal grey, has the 
capacity to activate descending nociceptive inhibitory mechanisms. 
However, several groups have shown dysfunctioning of endogenous analgesia in response to 
exercise in patients with chronic pain. Muscle contractions activate generalized endogenous 
analgesia in healthy, pain-free humans and patients with either osteoarthritis or rheumatoid 
arthritis, but result in increased generalised pain sensitivity in fibromyalgia patients. In patients 
having local muscular pain (e.g. shoulder myalgia), exercising non-painful muscles activates 
generalized endogenous analgesia. However, exercising painful muscles does not change pain 
sensitivity either in the exercising muscle or at distant locations. 
Limitations: The reviewed studies examined acute effects of exercise rather than long-term 
effects of exercise therapy. 
Conclusions: A dysfunctional response of patients with chronic pain and aberrations in 
central pain modulation to exercise has been shown, indicating that exercise therapy should be 
individually tailored with emphasis on prevention of symptom flares. The paper discusses the 
translation of these findings to rehabilitation practice together with future research avenues. 
Key words: Whiplash, fibromyalgia, chronic pain, low back pain, exercise, rehabilitation, 
chronic fatigue syndrome, osteoarthritis, rheumatoid arthritis, sensitization, shoulder
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Chronic pain remains a challenging issue for clinicians and researchers. Over the past decades, scientific understanding of such unexplained 
chronic pain disorders has increased substantially. It has 
now become clear that the majority of cases of chronic 
pain can be explained by alterations in central nervous 
system processing of incoming messages (1). More 
specifically, the responsiveness of central neurons 
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Based on this theoretical rationale and on the evi-
dence supporting the clinical benefits in various chronic 
musculoskeletal pain disorders, it is tempting to spec-
ulate that exercise can indeed desensitize the central 
nervous system. However, this hypothesis is not (yet) 
supported by scientific evidence. A recent systematic lit-
erature review showed that no conclusions can be made 
about the effect of exercise therapy on pain on pain-
modulatory substances (e.g. serotonin, norepinephrine, 
opioids) or on its effects on altering brain activity of 
areas involved in pain processing in patients with mus-
culoskeletal pain (20). Moreover, a dysfunctional re-
sponse of some patients with chronic musculoskeletal 
pain to exercise has been shown. Several populations 
of chronic pain patients are unable to activate central 
descending nociceptive inhibition (endogenous analge-
sia or EA) during exercise (21-23), a dysfunction partly 
explaining symptom flares following exercise (22). 
In what follows in this paper explains our current 
understanding of the biology of EA following exercise 
in humans. Next, it provides an overview of the stud-
ies addressing dysfunctional EA during local muscle 
and general aerobic exercise in patients with chronic 
pain. From this overview it will become clear that some 
chronic pain disorders (e.g. fibromyalgia) are character-
ized by a dysfunctional EA in response to both aero-
bic and local muscle exercises, while other chronic pain 
populations (e.g. chronic low back pain) show a normal 
activation of EA in response to exercise. The relevance 
of these findings to rehabilitation practice together 
with future research avenues will be discussed as well. 
The Biology of Exercise-Induced Endogenous 
Analgesia
Several partly overlapping mechanisms are sug-
gested to play a role in exercise-induced EA, includ-
ing release of endogenous opioids and growth factors 
(16,17), and activation of (supra)spinal nociceptive in-
hibitory mechanisms orchestrated by the brain (18,19). 
These mechanisms might be related to cardiovascular 
changes (i.e. increase in heart rate and blood pressure) 
during exercise, a notion supported by the finding that 
patients with hypertension show reduced pain sensi-
tivity (24). The interaction can be explained by similar 
brain stem nuclei, neurotransmitters (e.g. monoamines) 
and peptides (e.g. opioids) (25). The exercise-induced 
blood pressure increase activates arterial baroreceptors, 
resulting in increased supraspinal inhibition (24,25) and 
stimulation of brain centers involved in pain modula-
tion (26). 
to input from unimodal and polymodal receptors is 
augmented, resulting in a pathophysiological state 
corresponding to central sensitization, characterized by 
generalized or widespread hypersensitivity to a variety 
of stimuli (i.e. mechanical, thermal, and chemical) (2). 
The term central sensitization can be used to en-
compass altered sensory processing in the brain (3), 
long-term potentiation of brain synapses (4), impaired 
functioning of top-down anti-nociceptive mechanisms 
(5), and (over)activation of top-down pain facilatory 
pathways which augment nociceptive transmission 
(3,6). Importantly, a different “pain signature” arises in 
the brain of those with chronic pain. This altered pain 
neuromatrix comprises of a) increased activity in brain 
areas known to be involved in acute pain sensations 
like the insula, anterior cingulate cortex, and the pre-
frontal cortex, but not in the primary or secondary so-
matosensory cortex (7); and b) brain activity in regions 
generally not involved in acute pain sensations like vari-
ous brain stem nuclei, dorsolateral frontal cortex, and 
parietal associated cortex (7). Clinically central sensiti-
zation is characterized by non-segmental spreading of 
pain, “central” symptoms like concentration difficulties 
and fatigue, stress-intolerance and hypersensitivity to 
various stimuli like bright light, touch, and odors (8).  
Exercise is frequently encountered as a central com-
ponent of the treatment of patients with chronic pain. 
Exercise is an effective treatment for various chronic 
musculoskeletal pain disorders, including chronic low 
back pain (9), chronic whiplash associated disorders 
(10,11), osteoarthritis (12), and fibromyalgia (13,14). 
Although the clinical benefits of exercise therapy in 
these populations are well established (i.e. evidence 
based), it is currently unclear whether exercise therapy 
has positive effects on the processes involved in central 
sensitization. Is exercise capable of “treating” central 
sensitization in patients with chronic pain?  
There is a strong theoretical rationale suggesting 
that exercise therapy can indeed “treat” central sensi-
tization (or desensitize the central nervous system). In 
healthy individuals aerobic exercise of sufficient inten-
sity (+/- 200 W or 70 % VO2MAX) activates pain inhibi-
tion for up to 30 minutes post-exercise (15). Resistance 
exercise triggers endogenous analgesia as well, but it 
lasts for no more than a couple of minutes post-exercise 
(15). The exercise induced endogenous analgesia is pre-
sumed to be due to the release of endogenous opioids 
and growth factors (16,17) and activation of (supra)spi-
nal nociceptive inhibitory mechanisms orchestrated by 
the brain (18,19). 
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In addition, Hoffman and Thoren (27) have report-
ed that once blood pressure is displaced out of the basal 
range, either by physiological stimuli or pathophysi-
ological states, the endogenous opioid system becomes 
activated. Exercise triggers the release of β-endorphins 
from the pituitary (peripherally) and the hypothalamus 
(centrally), which in turn enables analgesic effects by 
activating µ-opioid receptors peripherally and centrally, 
respectively (28). The hypothalamus, through its projec-
tions on the periaqueductal grey, has the capacity to 
activate descending nociceptive inhibitory mechanisms.
Nevertheless, it appears from animal research that 
multiple analgesia systems exist (opioid and non-opi-
oid), and that properties of the exercise stressor are im-
portant in determining which system is activated during 
exercise. It has been shown that by manipulating the 
parameters of the exercise stressor, it is possible to elicit 
either naloxone-reversible or naloxone-insensitive EA 
following exercise (17,29). 
The role of growth hormone and growth factors in 
exercise-induced EA remains unclear. Some authors hy-
pothesize that growth hormone, via insulin-like growth 
factor and nerve growth factor, sensitizes rather than 
being involved in EA (30,31). Only one study evaluated 
the role of growth hormone in exercise-induced hypo-
algesia, but suppressing growth hormone production 
during exercise did not alter exercise-induced hypoal-
gesia (32). β-endorphins and growth hormone are re-
leased after a certain exercise span, one hour and 10 to 
40 minutes respectively, when lactate accumulation is 
leading to muscle acidosis (33-35). 
Catecholamines also exert direct analgesic effects. 
Main descending inhibitory action to the spinal dorsal 
horn are noradrenergic. In the dorsal horn, norepineph-
rine, through action on alpha-2A-adrenoceptors, sup-
presses release of excitatory transmitters from central 
terminals of primary afferent nociceptors (36). In addi-
tion it may suppress postsynaptical responses of spinal 
pain-relay neurons (36). Besides catecholamines, the 
mediators of the long-term stress response, namely cor-
ticosteroids, are involved in exercise induced EA. Both 
opioid and non-opioid mechanisms would contribute to 
the development of EA induced by glucocorticoids (37). 
Hence, exercise can be viewed as a frequent stressor ac-
tivating stress-induced analgesia. 
Other possible explanations for exercise-induced 
EA involve an increased body awareness for somatic 
sensations after exercise. This awareness of more sa-
lient signals—for example, sweating and heart pound-
ing—may divert attention away from the pain stimulus. 
Distraction can significantly alter pain perception (38). 
Furthermore, traditional gate control mechanisms, due 
to skin or muscle afferents competing with nociceptive 
afferents in the dorsal horn, may account for exercise 
induced EA. Finally, conditioned pain modulation, for-
merly referred to as diffuse noxious inhibitory controls 
(DNIC), may be activated subsequently to the nocicep-
tive barrage resulting from muscle ischemia and lactate 
accumulation. Peripheral mechanisms are less plausible 
as they typically result in sensitizing agents (prosta-
glandins, lactate, ischemia, growth factors, etc.).
Dysfunction of Endogenous Analgesia 
During Muscle Contraction in Patients with 
Musculoskeletal Pain
Long-term, low intensity, static work is a well 
known risk factor for the development of work-related 
myalgias, and static contractions increase pain intensity 
in patients with myalgia (39) and fibromyalgia (39,40). 
Animal studies have revealed that muscle ischemia is a 
potent cause of sensitization of peripheral mechanono-
ciceptors so that the increased intramuscular pressure 
caused by the contraction can became an effective no-
ciceptive stimulus (41). Compared to healthy controls, 
patients with shoulder myalgia (42) and fibromyalgia 
(43) had reduced muscle blood flow during static con-
tractions, which could lead to peripheral sensitization 
and explain the increased pain sensitivity reported in 
painful muscles in these patients (39). In accordance 
with this, increased sensitivity to pressure pain (i.e., 
increased tenderness) at the contracting muscle fol-
lowing static contractions was reported in fibromyal-
gia patients (44,45), suggesting dysfunctional EA dur-
ing exercise in these patients. Indeed, healthy subjects 
exhibited decreased pressure pain sensitivity at the 
contracting muscle during and following contraction 
indicating that segmental or possibly plurisegmental 
(generalized) pain inhibitory mechanisms were activat-
ed (46). In a follow-up study, localized (at the contract-
ing muscle) as well as generalized (at a distant resting 
muscle) pain inhibitory effects were seen during static 
contractions in healthy individuals (46). In addition, the 
decrease in pain sensitivity was of similar magnitude at 
the contracting and the distant resting muscle indicat-
ing the importance of generalized EA mechanisms (46).
To our knowledge, only a few studies have exam-
ined the effect of static contractions on pain sensitivity 
outside the contracting muscle. Staud et al (47) found 
a bilateral decrease in cutaneous (heat) and deep so-
matic (pressure) pain sensitivity during unilateral static 
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contractions sustained during 90 seconds correspond-
ing to 30% of the individual maximal voluntary con-
traction force (MVC) in healthy subjects. A paradoxical 
increase in heat and pressure pain sensitivity was seen 
bilaterally in fibromyalgia patients during the unilat-
eral contractions, providing evidence for widespread 
deficiency of EA or more pronounced pain facilitation 
in fibromyalgia patients during exercise (47). 
The important question raised by Staud et al (47) 
regarding the importance of deficient EA versus aug-
mented pain facilitation in pain patients during physical 
exercise was further addressed in another study assess-
ing patients with shoulder myalgia and fibromyalgia, 
respectively, during static contractions corresponding 
to 20 – 25% MVC until exhaustion (maximum 5 min-
utes) (39). Patients and healthy controls performed 
static contractions with M. quadriceps femoris and M. 
infraspinatus. Pressure pain thresholds were assessed 
before and during contraction at the contracting mus-
cle, the resting homologous contralateral muscle, and 
contralaterally at a distant site (M. infraspinatus during 
contraction of M. quadriceps and vice versa). Pressure 
pain thresholds increased at all sites during both con-
tractions in healthy controls, but no increase was seen 
at any site during contractions in fibromyalgia patients, 
who even exhibited increased pain sensitivity. Myalgia 
patients had an increase in pressure pain thresholds at 
all sites during contraction of the non-painful M. quad-
riceps, but no increase in pressure pain thresholds was 
seen at any site during contraction of the painful M. in-
fraspinatus. The authors suggested that nociceptive in-
put from painful muscles induced central sensitization 
and activated descending pain facilitatory mechanisms. 
The facilitatory mechanisms could override the contrac-
tion-induced pain inhibition and explain the lack of 
generalized EA during contraction of painful muscles in 
myalgia patients and the increased pain sensitivity dur-
ing contraction in fibromyalgia patients (39). 
Interestingly, a pilot study in patients with rheu-
matoid arthritis indicates normal EA during static con-
traction in these patients (Fridén et al., submitted) and 
preliminary results also indicate normal function of these 
mechanisms in patients with osteoarthritis of the knee 
and hip (Kosek, Roos, Nilsdotter, manuscript in prepara-
tion). These findings are in accordance with the reported 
beneficial effects of exercise in these conditions (48,49). 
As mentioned, many potential mechanisms have 
been implicated in pain regulation during muscle 
contractions. Conditioned pain modulation has been 
proposed as one possible mechanism for pain inhibi-
tion during contraction. However, the low pain ratings 
during contraction in healthy controls (39) make this 
unlikely. Furthermore, although a dysfunction of con-
ditioned pain modulation has been shown in fibromy-
algia (50), normal function of conditioned pain mod-
ulation was shown in shoulder myalgia patients (51). 
Exercise induced pain modulation during static con-
tractions has also been related to arterial baroreceptor 
activation in humans (52). However, a normal increase 
in heart rate and blood pressure has been reported in 
fibromyalgia patients during static contractions offset-
ting abnormal cardiovascular response to exercise as a 
likely explanation for the dysfunction of EA in these pa-
tients (40,53). Finally, hormonal factors of importance 
for regulation of muscle blood flow and pain sensitiv-
ity could be of interest. The findings of a hypo-active 
sympatho-adrenal system in combination with a hypo-
reactive adrenal-hypothalamo-pituitary (HPA) axis in 
fibromyalgia patients during static contractions could 
contribute to the dysfunctional EA during exercise and 
subsequent exercise intolerance that is so characteristic 
for fibromyalgia patients (53). 
It is concluded that muscle contractions activate 
generalized EA in healthy, pain-free humans and pa-
tients with either osteoarthritis and rheumatoid arthri-
tis, but result in increased generalised pain sensitivity in 
fibromyalgia patients. In patients having local muscu-
lar pain (e.g. shoulder myalgia), exercising non-painful 
muscles activates generalized EA. However, exercising 
painful muscles does not change pain sensitivity either 
in the exercising muscle or at distant locations. 
Dysfunction of Endogenous Analgesia 
During Aerobic Exercise in Patients with 
Musculoskeletal Pain
The dysfunctional EA in response to aerobic exer-
cise was first shown in a small study of patients with 
chronic fatigue syndrome and healthy controls in which 
participants performed a graded exercise with 3 stages 
on a treadmill (54). Every stage of the exercise consisted 
of 5 minutes walking at a constant pace of 5km/h, with 
an increasing incline of 5°. Dysfunctional EA was dem-
onstrated by decreased pain thresholds following ex-
ercise in patients with chronic fatigue syndrome, while 
pain thresholds increased in healthy controls. These 
findings were later replicated in 2 larger studies using 
various types of exercise: 
1) submaximal cycle exercise with a gradual increase of 
25 W every minute until 75% of the age-predicted 
target heart rate was achieved (22), 
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2) 6 short bouts of aerobic cycling interrupted by short 
recovery breaks (21), and 
3) physiologically limited (heart rate below 80% of the 
anaerobic heart rate, workload below 80% of the an-
aerobic workload) and self-paced aerobic cycling (22). 
From these studies it is concluded that neither 
types of aerobic exercise were able to activate EA in 
patients with chronic fatigue syndrome who experience 
chronic widespread pain. Importantly, the dysfunctional 
EA partly explains symptom flares following exercise in 
patients with chronic fatigue syndrome having chronic 
widespread pain (22). 
A similar dysfunctional EA in response to exercise 
and symptom flares following exercise was shown in pa-
tients with chronic whiplash associated disorders (23), 
suggesting this to be a feature of central sensitization. 
The dysfunctional EA in patients with chronic whiplash 
associated disorders was observed during submaximal 
cycle exercise with a gradual increase of 25 W every 
minute until 75% of the age-predicted target heart 
rate was achieved, as well as during physiologically lim-
ited and self-paced aerobic cycling (23). Remarkably, in 
the studies outlined above the various types of aerobic 
exercise did activate EA in healthy sedentary controls 
(21-23,54) and patients with chronic low back pain (21). 
The latter confirms an earlier study in chronic low back 
pain patients (55). Thus, the mechanism of EA in pa-
tients with chronic low back pain responds normally to 
aerobic exercise.  
Some work has been performed to unravel the 
mechanisms behind the dysfunctional EA during exer-
cise in certain chronic pain disorders. Nitric oxide (NO) 
plays a complex role in nociceptive processing (19). Al-
though evidence exists regarding the beneficial effects 
of the release of small amounts of NO during inhibition 
of nociceptive pathways (56), excessive amounts of NO 
could contribute to central sensitization. Indeed, NO is 
able to reduce the nociceptive inhibitory activity of the 
central nervous system, leading to central sensitization 
of dorsal horn neurones (57). A single bout of physi-
cal activity triggers release of NO (58), leading to the 
hypothesis that the dysfunctional EA during exercise 
might be due to NO release. However, NO levels were 
unrelated to pain processing during aerobic exercise in 
healthy sedentary controls, patients with chronic fa-
tigue syndrome and chronic low back pain (21). 
While endogenous opioid and adrenergic pain-
inhibitory mechanisms might account for activation of 
EA during exercise in healthy individuals (18,19), direct 
evidence is lacking. Therefore, a study was undertak-
en to examine the contribution of endogenous opioid 
pain-inhibitory mechanisms during exercise in 2 chronic 
pain populations: rheumatoid arthritis and fibromy-
algia/chronic fatigue syndrome (59). In a randomized 
and placebo-controlled cross-over study, we modulated 
endogenous opioid and serotonergic pain-inhibitory 
mechanisms during exercise by using selective sero-
tonin reuptake inhibitor (SSRI; 2 mL of citalopram in-
travenously) during the DNIC and temporal summation 
model in response to exercise. SSRIs activate serotoner-
gic descending pathways that recruit, in part, opioid 
peptide-containing interneurons of the dorsal horn 
(60). Unfortunately, significant side effects immediately 
after intravenous administration of citalopram resulted 
in early cessation of the study. Hence, currently no con-
clusions can be made addressing the role of serotoner-
gic descending pathways in EA in response to exercise 
in chronic pain patients (59). 
It is concluded that the dysfunctional EA during 
aerobic exercise is not characteristic for all chronic pain 
patients, but rather limited to those with clear evidence 
of central sensitization (e.g. chronic whiplash, fibromy-
algia, chronic fatigue syndrome). 
Analgesic Effects of Exercise Therapy in 
Patients with Chronic Musculoskeletal Pain: 
Opportunities and Challenges
Applying these Findings to the Practice of Exercise 
Therapy for Chronic Pain
When confronted with the cumulating evidence for 
a dysfunctional EA during exercise in some chronic pain 
disorders, one might wonder whether we should con-
tinue using exercise therapy in these patients. However, 
this should not be an issue. The studies summarized 
above address acute bouts of exercise, not findings 
from randomized clinical trials examining the effects 
of exercise as a therapeutic intervention. The stud-
ies showing dysfunctional EA during exercise in some 
chronic pain conditions do not contradict the clinical 
evidence favoring the use of exercise as an intervention 
for chronic pain. Exercise is an effective treatment for 
chronic whiplash associated disorders (10,11), fibromy-
algia (13,14), chronic fatigue syndrome (61,62), osteo-
arthritis (48), and rheumatoid arthritis (49). Hence, its 
clinical use and benefits should not be questioned. To 
exercise or not to exercise patients with chronic pain, is 
no longer the question. 
On the other hand, the dysfunctional EA during 
exercise in patients with chronic pain should not be 
Pain Physician: Opioid Special Issue July 2012; 15:ES205-ES213
ES210  www.painphysicianjournal.com
ignored. In fact, its clinical relevance is supported by 
studies showing that symptom flares following exercise 
are related to the dysfunctional EA during exercise (22). 
In addition, the dysfunctional EA during exercise might 
explain the low compliance with exercise interventions 
in chronic pain patients. Typically the early stages of ex-
ercise therapy programs are prone to dropouts. 
Lack of exercise-induced analgesia implies a de-
creased pain threshold following exercise. This makes 
patients vulnerable for new nociceptive input. Exercise 
is typically associated with myofiber damage and sub-
stances released in response to exercise (e.g. oxidative 
stress, lactate), potentially providing increased noci-
ceptive input in response to exercise (63). Hence, the 
dysfunctional EA during exercise increases the risk of 
severe symptom flares following exercise sessions. For 
all these reasons, we conclude that clinicians should ac-
count for the dysfunctional EA during exercise in cer-
tain chronic pain conditions.
But how? Given the dearth of studies examining 
the effects of exercise therapy on EA (20), this ques-
tion can only be answered by applying logical (clinical) 
reasoning. Appropriately tailored and graded exercise 
therapy has been suggested as a treatment for central 
sensitization in patients with chronic pain (64), but evi-
dence supporting this notion is lacking (20). Especially 
in the early stages of exercise therapy programs, exer-
cise therapy should be individually tailored with em-
phasis on prevention of symptom flares. 
This might be achieved by applying the following 
guidelines (Table 1): prefer aerobic exercise over eccen-
tric or isometric muscle work, as the latter 2 are likely 
to increase the hyperexcitability of the central nervous 
system (47) and result in diminished blood flow increase 
in the working muscles (43). The findings from the stud-
ies explained above suggest that exercising preferably 
non-painful parts of the body could have pain-relieving 
effects in myalgia patients by reducing pain sensitivity 
in painful muscles, while low intensity training regimes 
would be expected to be favorable in fibromyalgia in 
order to avoid unnecessary exacerbations of pain (39). 
In addition, exercise therapy for chronic pain pa-
tients should account for cognitive-emotional sensiti-
zation. Emotions, attention, expectations, depressive 
thoughts, and catastrophic thoughts each enhance de-
scending facilitation (65-67), which in turn sustains the 
process of central sensitization. This is typically referred 
to as cognitive-emotional sensitization (68), which can 
imply increased forebrain activity that can exert power-
ful influences on various brainstem nuclei (69), including 
those identified as the origin of descending facilitatory 
pathways (70). Clinically cognitive-emotional sensitiza-
tion is typically addressed in comprehensive pain man-
agement programs that include pain physiology educa-
tion to address illness perceptions and maladaptive pain 
cognitions, stress management, time-contingent activity 
management (i.e. graded activity), and time-contingent 
exercise therapy (i.e. graded exercise therapy) (Table 1).
Table 1. Practical guidelines to account for dysfunctional endogenous analgesia during exercise when applying exercise therapy in 
patients with chronic musculoskeletal pain. 
Keep the following guidelines in mind when applying exercise therapy in patients with chronic 
musculoskeletal pain and dysfunctional endogenous analgesia during exercise:
♦ exercise should be fun, not a burden
♦ Discuss the content of the exercise protocol with the patient; it should fit the needs and requests of the patient
♦ Use aerobic exercise as well as motor control training
♦ Be careful with eccentric exercise 
♦ Include exercise of non-painful parts of the body 
♦  Allow increased pain during and shortly following exercise but avoid continuously increasing pain intensity over time 
(i.e. modify exercise) 
♦ Use a time-contingent approach with appropriate baseline
♦  Be conservative when setting the baseline; prefer a lower baseline to guarantee that is well within the capabilities of the 
patient’s body
♦ Use multiple and long recovery breaks in between exercises 
♦  Monitor symptom flares, especially during initiation of treatment and during grading, and adopt exercise modalities 
accordingly
♦  Minor symptom flares are natural during initial stages of exercise therapy, but should cease once an exercise routine is 
established
♦ Do not grade the exercise protocol in case of major symptom flares
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Treatment of the Dysfunctional Endogenous 
Analgesia During Exercise by Combining Centrally 
Acting Drugs with Exercise Therapy?  
In addition to the guidelines for designing appro-
priate exercise therapy programs, it seems rational to 
combine centrally acting drugs with exercise therapy. 
Unraveling the mechanisms responsible for the dysfunc-
tional EA in response to exercise in people with chronic 
pain is likely to be a crucial step towards well-balanced 
drug + exercise treatments. In the mean time, the fol-
lowing suggestions seems rational given our current 
understanding of dysfunctional EA during exercise and 
chronic pain management. First, opioid use in combina-
tion with (the early stages) of graded exercise therapy 
might be an option in some patients with nociceptive 
pain. In this respect, it is important to realize that evi-
dence indicates that opioid withdrawal is unnecessary 
for effective pain rehabilitation programs (71). This is 
important as the early pain rehabilitation programs ad-
vocated operant methods to decrease opioid consump-
tion in the early treatment stages. 
Second, activation of serotonergic and/or nor-
adrenergic descending pathways in conjunction with 
graded exercise therapy might be an option. A cen-
trally acting analgesic like Duloxetine, a selective and 
balanced serototin and norepinephrine reuptake in-
hibitor (SNRI), has proven its efficacy in a variety of 
chronic pain conditions characterized by central sensi-
tization (e.g. fibromyalgia [72] and osteoarthritis [73]). 
It remains unclear whether these clinical effects can be 
reinforced by combining drug use with graded exercise 
therapy. Further work in this area is warranted. 
Finally, the finding that peak exercise performance 
in healthy people improves when using acetaminophen 
(74) might provide a new avenue for combining analge-
sics with exercise therapy for patients with chronic pain 
and dysfunctional EA during exercise. There is evidence 
suggesting that acetaminophen primarily acts centrally 
by reinforcing descending inhibitory pathways (75), 
namely the serotonergic descending pain pathways. 
Still, future research should examine whether these 
proposed combinations of drug treatment and graded 
exercise therapy are able to treat the dysfunctional EA 
in patients with chronic pain. Moreover, the combined 
treatment programs should not only improve EA dur-
ing exercise, it should benefit the patient at the level of 
daily functioning and quality of life as well. 
ConClusion
Exercise activates EA in healthy individuals, result-
ing in generalized increased pain tolerance during and 
immediately following exercise. This conclusion ac-
counts for aerobic exercises like cycling, and for exercis-
ing local muscle groups. The physiological mechanisms 
explaining EA following exercise have not been stud-
ied in detail yet, but the available research data sug-
gest that it is due to the release of endogenous opioids 
and activation of (supra)spinal nociceptive inhibitory 
mechanisms orchestrated by the brain. However, aero-
bic exercise activates pain facilitation rather than inhi-
bition in some patients with chronic pain and central 
sensitization (fibromyalgia, whiplash, and chronic fa-
tigue syndrome). Exercising local muscle groups results 
in increased generalised pain sensitivity in fibromyalgia 
patients, but recent data indicate that this might not 
be the case in those with osteoarthritis and rheumatoid 
arthritis. In shoulder myalgia, exercising non-painful 
muscles activates generalized EA, but exercising painful 
muscles does not activate EA. Further work is required 
to unravel the biology of the dysfunctional EA follow-
ing exercise, and to establish how these findings should 
be applied to clinical practice. 
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